111 S. Calvert Street
Suite 1800
Baltimore, MD
21202
443-573-3700
www.cscp.com


Andrew L. John
Managing Director
443-573-3710
ajohn@cscp.com


Steven A. Axel
Managing Director
443-573-3709
saxel@cscp.com


Gregory W. Barger
Managing Director
443-573-3712
 gbarger@cscp.com


Christopher C. Hammond
Principal
443-573-3718
chammond@cscp.com


Sarah P. Cheplak
Associate
443-573-3711
scheplak@cscp.com

Mezzanine Capital


Calvert Street invests $7.025 million in 
Everett Laboratories, Inc.

everett labs Tombstone-small
Everett Laboratories, Inc.  

CSCP recently completed a $7.025 million investment in Everett Laboratories, Inc. ("Everett").  Everett, headquartered in West Orange, New Jersey was founded in 1971 and has become a leading developer and marketer of niche prescription pharmaceutical and nutraceutical products.  CSCP's investment supported the recapitalization of the company by Mangrove Equity Partners.  Sun Mergers & Acquisitions, LLC initiated the transaction, and served as financial advisor to Everett and process manager for the transaction.


Calvert Street Capital Partners - Mezzanine Capital

CSCP's Mezzanine Fund, with $120 million of committed capital, provides subordinated debt primarily to support private equity-sponsored transactions.  Our investment size is $3 million to $10 million.  Please contact us to discuss how we may assist you.

           Mezzanine Capital for the Lower Middle Market